» Articles » PMID: 33941094

Infant Rhesus Macaques As a Non-human Primate Model of Bordetella Pertussis Infection

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2021 May 4
PMID 33941094
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalent resurgence of pertussis has recently become a critical public health problem worldwide. To understand pertussis pathogenesis and the host response to both the pathogen and vaccines, a suitable pertussis animal model, particularly a non-human primate model, is necessary. Recently, a non-human primate pertussis model was successfully established with baboons. Rhesus macaques have been shown to be ideal animal models for several infectious diseases, but a model of infectious pertussis has not been established in these organisms. Studies on rhesus macaque models of pertussis were performed in the 1920s-1930s, but limited experimental details are available. Recent monkey pertussis models have not been successful because the typical clinical symptoms and transmission have not been achieved.

Methods: In the present study, infant rhesus macaques were challenged with Bordetella pertussis (B.p) using an aerosol method to evaluate the feasibility of this system as an animal model of pertussis.

Results: Upon aerosol infection, monkeys infected with the recently clinically isolated B.p strain 2016-CY-41 developed the typical whooping cough, leukocytosis, bacteria-positive nasopharyngeal wash (NPW), and interanimal transmission of pertussis. Both systemic and mucosal humoral responses were induced by B.p.

Conclusion: These results demonstrate that a model of pertussis was successfully established in infant rhesus macaques. This model provides a valuable platform for research on pertussis pathogenesis and evaluation of vaccine candidates.

Citing Articles

Impact of outdoor air pollution on the incidence of pertussis in China: a time-series study.

Xu Y, Luo Y, Yue N, Nie D, Ai L, Zhu C BMC Public Health. 2023; 23(1):2231.

PMID: 37957620 PMC: 10642023. DOI: 10.1186/s12889-023-16530-w.


Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against in a Mouse Model.

Jiang W, Wang X, Su Y, Cai L, Li J, Liang J Front Immunol. 2022; 13:878832.

PMID: 35493458 PMC: 9043693. DOI: 10.3389/fimmu.2022.878832.


Non-primate animal models for pertussis: back to the drawing board?.

Cimolai N Appl Microbiol Biotechnol. 2022; 106(4):1383-1398.

PMID: 35103810 PMC: 8803574. DOI: 10.1007/s00253-022-11798-1.


Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model.

Wang X, Gao N, Wen J, Li J, Ma Y, Sun M Vaccines (Basel). 2022; 10(1).

PMID: 35062708 PMC: 8779802. DOI: 10.3390/vaccines10010047.


Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses.

Zuo W, Li J, Jiang W, Zhang M, Ma Y, Gu Q Front Microbiol. 2021; 12:757375.

PMID: 34759909 PMC: 8573275. DOI: 10.3389/fmicb.2021.757375.

References
1.
Bart M, Harris S, Advani A, Arakawa Y, Bottero D, Bouchez V . Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio. 2014; 5(2):e01074. PMC: 3994516. DOI: 10.1128/mBio.01074-14. View

2.
Clarke M, McIntyre P, Blyth C, Wood N, Octavia S, Sintchenko V . The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. J Infect. 2015; 72(2):171-8. DOI: 10.1016/j.jinf.2015.11.004. View

3.
Mooi F, van Loo I, van Gent M, He Q, Bart M, Heuvelman K . Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009; 15(8):1206-13. PMC: 2815961. DOI: 10.3201/eid1508.081511. View

4.
Li L, Deng J, Ma X, Zhou K, Meng Q, Yuan L . High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016. Emerg Infect Dis. 2019; 25(12):2205-2214. PMC: 6874251. DOI: 10.3201/eid2512.181836. View

5.
Zimmerman L, Papin J, Warfel J, Wolf R, Kosanke S, Merkel T . Histopathology of Bordetella pertussis in the Baboon Model. Infect Immun. 2018; 86(11). PMC: 6204705. DOI: 10.1128/IAI.00511-18. View